Members |
targetComponentId |
Potassium chloride 15meq |
Potassium chloride only product |
kaliumklorid 15 milliekvivalenter per förpackning |
Potassium chloride only product |
kaliumklorid 1 000 mg/5 ml, lösning |
Potassium chloride only product |
kaliumklorid 1 000 mg/ml, lösning |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
kaliumklorid 20 %, injektionsvätska, lösning, ampull |
Potassium chloride 200 mg/mL solution for injection |
kaliumklorid 20 %, lösning |
Potassium chloride only product |
kaliumklorid 20 milliekvivalenter, pulver |
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) |
Potassium chloride 20meq/15m solution |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
kaliumklorid 20 milliekvivalenter/15 ml, lösning |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
kaliumklorid 20 milliekvivalenter per förpackning |
Potassium chloride only product |
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 500 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
glukos 5 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection |
glukos 5 % + kaliumklorid 20 millimol, infusionsvätska, lösning, påse 500 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection |
natriumklorid 0,9 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml |
Product containing precisely potassium chloride 1.5 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
natriumklorid 0,9 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 500 ml |
Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
glukos 5 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for injection |
natriumklorid 0,9 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1000 ml |
Product containing precisely potassium chloride 2 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
glukos 5 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection |
natriumklorid 0,9 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml |
Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kaliumklorid 7,5 %, sirap |
Product containing only potassium chloride in oral dose form (medicinal product form) |
injektionskoncentrat kaliumklorid 15 %, lösning, ampull |
Product containing only potassium chloride in parenteral dose form (medicinal product form) |
kaliumcitrat 12 g/10 ml koncentrerad blandning |
Product containing only potassium citrate in oral dose form (medicinal product form) |
kaliumcitrat 12 g/10 ml, oral lösning |
Product containing only potassium citrate in oral dose form (medicinal product form) |
kaliumcitrat 3 g/dospåse, granulat |
Product containing only potassium citrate in oral dose form (medicinal product form) |
biverkningar av kaliumklorazepat |
Adverse reaction to clorazepate |
kaliumglukonat 20 milliekvivalenter/15 ml, elixir |
Product containing precisely potassium gluconate 312 milligram/1 milliliter conventional release oral solution (clinical drug) |
kaliumpermanganat 400 mg, tablett till kutan lösning |
Product containing permanganic acid in cutaneous dose form (medicinal product form) |
kaliumpermanganat 400 mg, tablett till lösning |
Product containing permanganic acid in cutaneous dose form (medicinal product form) |
kaliumfosfat 2 mmol/ml, injektionsvätska, lösning, ampull 10 ml |
Product containing precisely monobasic potassium phosphate 136 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kaliumtillskott |
Potassium and/or potassium compound |
potatis, livsmedel |
Potato (substance) |
potentiell exponering för infektion |
Exposure to organism (event) |
Potential infectious contact |
Exposure to organism (event) |
Potential infectious contact |
Exposure to organism (event) |
Potexvirus group |
Genus Potexvirus (organism) |
Potts fraktur |
Bimalleolar fracture of ankle |
Pouched mammal |
Infraclass Metatheria (organism) |
povidon 5 %, ögondroppar |
Povidone 50 mg/mL eye solution |
povidon 5 %, ögondroppar för engångsbruk |
Povidone 50 mg/mL eye solution |
joderad povidon 10 % |
Product containing povidone iodine (medicinal product) |
joderad povidon 10 %, preparat för pensling |
Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
joderad povidon 10 %, svamp för lokalt bruk |
Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
joderad povidon 10 %, vaginalgel |
Iodine (as povidone iodine) 100 mg/g vaginal gel |
joderad povidon 20 %, svamp för lokalt bruk |
Povidone iodine only product in cutaneous dose form |
joderad povidon 200 mg, suppositorium |
Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug) |
joderad povidon 5 %, svamp för lokalt bruk |
Product containing precisely povidone iodine 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
pulver till instillationslösning för luftvägarna |
Powder for solution for endotracheopulmonary instillation |
pulver till suspension för endotrakeal instillation |
Powder for conventional release suspension for endotracheopulmonary instillation (dose form) |
pulver till suspension |
Powder (basic dose form) |
Powered wheelchair |
Motorized wheelchair device (physical object) |
Poxvirus group |
Family Poxviridae (organism) |
Pramipexole dihydrochloride 125micrograms tablet |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 88 microgram/1 each conventional release oral tablet (clinical drug) |
Pramipexole dihydrochloride 1mg tablet |
Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet |
Pramipexole dihydrochloride 250micrograms tablet |
Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet |
pramlintid 1 mg/ml, injektionsvätska, lösning, förfylld penna |
Pramlintide only product |
Pre-excitation atrioventricular conduction |
Accelerated atrioventricular conduction |
befintlig terapi ändrad av anestesiolog preoperativt |
Pre-existing therapy altered by anesthetist preoperatively (situation) |
duplexvaccination mot difteri och stelkramp i förskoleåldern |
Preschool administration of diphtheria and tetanus vaccine |
Precautionary nursing procedure |
Nursing procedure |
Prediabetes |
Impaired glucose tolerance |
prednisolon 0,001 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 10 microgram/mL eye solution |
prednisolon 0,003 %, ögondroppar |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 30 microgram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,01 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
prednisolon 0,01 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
prednisolon 0,01 %, ögondroppar utan konserveringsmedel |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
prednisolon 0,03 %, ögondroppar |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,03 %, ögondroppar |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,03 %, ögondroppar utan konserveringsmedel |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,1 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
prednisolon 0,1 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
prednisolon 0,1 %, ögondroppar utan konserveringsmedel |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
prednisolon 0,3 %, ögondroppar |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,3 %, ögondroppar |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,3 %, ögondroppar utan konserveringsmedel |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Prednisolone 20mg/100mL enema |
Prednisolone only product in rectal dose form |
Prednisolone 20mg/100mL enema |
Prednisolone only product in rectal dose form |
prednisolon 20 mg/100 ml, retentionslavemang som administreras med lång slang |
Prednisolone only product in rectal dose form |
prednisolon 20 mg/100 ml, retentionslavemang som administreras med standardslang |
Prednisolone only product in rectal dose form |
prednisolon 5 mg, löslig tablett |
Product containing precisely prednisolone 5 milligram/1 each conventional release orodispersible tablet (clinical drug) |
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, salva |
Prednisolone and sulfacetamide only product in ocular dose form |
Prednisolone acetate 25mg/mL |
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
prednisolonacetat 25 mg/ml, suspension |
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
allergi mot prednisolondroppar |
Allergy to prednisolone |
prednisolonhexanoat 1,3 mg + cinkokain 1 mg, suppositorium |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) |
prednisolonnatriumfosfat 0,5 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
prednisolonnatriumfosfat 0,5 %, ögondroppar för engångsbruk |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
prednisolonnatriumfosfat 1 %, lösning |
Product containing precisely prednisolone sodium phosphate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
prednisolonnatriumfosfat 1/8 %, lösning |
Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
preferens för temperatur på dryck |
Preference for temperature of drink (observable entity) |
preferens för temperatur på mat |
Preference for temperature of food (observable entity) |
Preglaucoma |
Glaucoma suspect |
substansberoende under graviditet |
Pregnancy and substance dependence (disorder) |
förlängd graviditet-41 veckor |
Prolonged pregnancy (disorder) |
förlängd graviditet-42 veckor |
Prolonged pregnancy (disorder) |
Pregnancy, childbirth and puerperal disorders |
Disorder of pregnancy |
prematur onormal placenta |
Premature aging of placenta |
Premature ejaculation |
Premature ejaculation |
underburet foster |
Prematurity of infant (disorder) |